In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Philip A. Philip, MD, PhD, FRCP, FABC
Professor of Oncology, Pharmacology and Medicine
Kathryn Cramer Endowed Chair in Cancer Research
Vice President of Medical Affairs
Leader, GI and Neuroendocrine Tumors
Department of Oncology
Karmanos Cancer Institute
Wayne State University
Dr. Philip is on the advisory boards of bioTheranostics, Caris, Celgene, EMD Serono, Halozyme, Lexicon and Merrimack; receives grants/research support from Acerta, Bayer, Celgene, Immunomedics, Incyte, Karyopharm, Lilly, Merck, Momenta, Novartis, Roche, Taiho and XBiotech; and is a speaker for Amgen, Celgene, Genentech and Novar
Eileen M. O’Reilly, MD
Associate Director, Clinical Research
David M. Rubenstein Center for Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, NY
Dr. O’Reilly receives consulting fees from Aduro Biotech Agios, Array, Aslan, Astellas Pharma US, Bayer, Blueprint, Boston Scientifc, BMS, Celgene, CASI, Celsion, Delcath, Eisai, EMD Sorono, Gilead, Halozyme, Integragen, Ipsen, Janssen, Merck, Merrimack, Momenta, New B Innovation, NewLink Genetics, Onxeo, Opsona, Pfizer, Roche, Sanofi-aventis, Servier, Silenseed, Sillajen, Sirtex, Vaxxim, Vicus Therapeutics, and Westhaven and contracted research for Amgen, Astra Zeneca, BMS, Bayer, CASI, Celgene, Chugai, Exelixis, Genentech, Incyte, Lilly, Mabvax, Medimmune, Momenta, Myriad Genetics, OncoMed Pharmaceuticals Polaris Pharmaceuticals, Roche, and Vicus Therapeutics.
- Sean T. Barrett, CHCP has nothing to disclose.
- Barry A. Fiedel, PhD has nothing to disclose.
- Kia K. Gray, MPH has nothing to disclose.
- Amanda Hilferty has nothing to disclose.
- Nick Lombardi has nothing to disclose.
- Jennifer Spear Smith, PhD has nothing to disclose.